Letters
Hypocalcaemia after intravenous bisphosphonate
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7453.1439-c (Published 10 June 2004) Cite this as: BMJ 2004;328:1439
Authors' reply
- Rajesh Peter, senior house officer,
- Vinita Mishra, specialist registrar,
- William D Fraser, professor (w.d.fraser@liverpool.ac.uk)
- Department of Clinical Chemistry, Royal Liverpool University Hospital, Liverpool L69 3GA
- Department of Clinical Chemistry, Royal Liverpool University Hospital, Liverpool L69 3GA
- Department of Clinical Chemistry, Royal Liverpool University Hospital, Liverpool L69 3GA
EDITOR—The word limit for lessons of the week can result in removal of discussion points during editing. We considered several of Breay's and Fergus's comments in early versions of our article. Their points are valid, and doctors prescribing bisphosphonates must read the product information and understand what can happen if the prescribing guidelines are not followed.
Our cases highlighted severe hypocalcaemia after bisphosphonate treatment, and, although mild hypocalcaemia is a well documented side effect, we are …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.